Type 2 Diabetes Specialty Roundtable:
A Quest for Quality Patient Care

  • ON DEMAND WEBINAR
  • 2 HOURS
This expert-led Clinical Practice Update brings together endocrinology, cardiology, and nephrology specialists to explore how SGLT2 inhibitors and GLP-1 receptor agonists can optimize outcomes in type 2 diabetes.

Learn how to apply the 2024 Diabetes Canada pharmacotherapy update to real-world care, with insights on cardiovascular and renal protection, combination therapy, and quality improvement strategies in primary care.

This program is made possible through support by Boehringer Ingelheim Canada.

Meet the Faculty

Alex Abitbol

MDCM, FRCPC

Peter Lin

MD, CCFP

Louise Moist

MD, CCPE

Ronald Goldenberg

MDM, FRCPC, FACE

Kim Connelly

MBBS, PhD, FSCMR, FCCS

Start Learning

Share this program with your peers